HEALTH NEWS
Amgen May Slow Spread of Cancer
Posted: Feb 6, 2012 8:20 AM by Associated Press (DS)
WASHINGTON (AP) - Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.
The Food and Drug Administration will ask a panel of outside experts on Wednesday whether the benefits of Amgen's Xgeva (ex-jeev'-ah) outweigh its risks, which included bone disease in about 5 percent of patients taking the drug.
Xgeva is already approved for preventing fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Now Amgen has asked the FDA to approve its injectable drug for men with recurring prostate cancer that is at high risk of spreading to the bone. Men must have also attempted and failed treatment with hormone therapy.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at feedback@ksby.com, and include the name of the story and information on the comment.
Thank you! KSBY.com
KSBY.com is social!
Most Popular
HotSpot
California Mid-State Fair
The California Mid-State Fair is just around the corner. See what's coming up!
Calendar
Wondering what to do this weekend? Check out our calendar of events across the Central Coast.
CA Lottery
Did you win? Check your numbers here. KSBY, the official CA Lottery station for the Central Coast.
KSBY.COM VIDEOS
Comments